The ROE as of November 2024 (TTM) for Jasper Therapeutics, Inc. (JSPR) is -67.65%

According to Jasper Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -67.65%. This represents a change of 286.15% compared to the average of -17.52% of the last 4 quarters.

Jasper Therapeutics, Inc. (JSPR) Historical ROE (quarterly & annually)

How has JSPR ROE performed in the past?

The mean historical ROE of Jasper Therapeutics, Inc. over the last ten years is -23.47%. The current -67.65% ROE has changed 188.25% with respect to the historical average. Over the past ten years (40 quarters), JSPR's ROE was at its highest in in the December 2020 quarter at 28.43%. The ROE was at its lowest in in the September 2020 quarter at -216.50%.

Jasper Therapeutics, Inc. (JSPR) ROE by Quarter and Year

Discovering the peaks and valleys of Jasper Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Jasper Therapeutics, Inc. (JSPR) Average ROE

How has JSPR ROE performed in the past?

The current ROE of Jasper Therapeutics, Inc. (JSPR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Jasper Therapeutics, Inc. (JSPR) ROE vs. Peers

How is JSPR’s ROE compared to its peers?

Jasper Therapeutics, Inc.’s ROE is greater than Lyra Therapeutics, Inc. (-178.68%), greater than Equillium, Inc. (-20.68%), greater than HOOKIPA Pharma Inc. (-49.25%), greater than LianBio (-21.53%), greater than Acumen Pharmaceuticals, Inc. (-32.99%), less than Galera Therapeutics, Inc. (21.95%), greater than Inozyme Pharma, Inc. (-88.42%), less than Eledon Pharmaceuticals, Inc. (21.51%), greater than Icosavax, Inc. (-20.22%), greater than Edgewise Therapeutics, Inc. (-26.83%), greater than Ikena Oncology, Inc. (-39.59%), greater than Design Therapeutics, Inc. (-18.01%), greater than Xilio Therapeutics, Inc. (-214.74%), greater than Eliem Therapeutics, Inc. (-47.03%), less than POINT Biopharma Global Inc. (0%), greater than ORIC Pharmaceuticals, Inc. (-11.52%), greater than Inhibrx Biosciences, Inc. (-42.46%), less than ESSA Pharma Inc. (1.45%), greater than null (-20.17%),

Build a custom stock screener for Jasper Therapeutics, Inc. (JSPR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jasper Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jasper Therapeutics, Inc. (JSPR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jasper Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.